← Eichor
Study identifier: NCT06296485 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safer Aging With Diabetes Monitoring

Condition: Diabetes Mellitus, Type 2 · Hypoglycemia  ·  Sponsor: Kaiser Permanente

PhaseNA
Planned participants360
Who can joinAll sexes, 75 Years to no upper limit
Healthy volunteersNo

About this study

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

This description comes directly from the study's public registry record.

Talk to the study team

Carolina Gonzalez  ·  866-206-2969  ·  Susana.C.Gonzalez@kp.org

Nancy W Charvat-Aguilar  ·  nancy.x.charvat-aguilar@kp.org

Always discuss trial participation with your own doctor first.

Locations (4)

Kaiser Permanente FremontFremont, California, United StatesRecruiting
Kaiser Permanente San JoseSan Jose, California, United StatesRecruiting
Kaiser Permanente San LeandroSan Leandro, California, United StatesRecruiting
Kaiser Permanente - Union CityUnion City, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06296485